| 1 | 1446144-71-3 | 乙酰胺基他达拉非 | AcetaMinotadalafil | C23H20N4O5
| 医药原料 | 医药原料;Inhibitors, Pharmaceuticals, Intermediates & Fine Chemicals |
| 2 | 445006-97-3 | N-[3-(N-{4-nitrobenzoyl}ethanehydrazonoyl)phenyl]-2-phenoxyacetamide | N-[3-(N-{4-nitrobenzoyl}ethanehydrazonoyl)phenyl]-2-phenoxyacetamide | C23H20N4O5
| | |
| 3 | 512812-10-1 | 5-({2-nitro-4-methylphenoxy}methyl)-N-[4-(1H-pyrazol-1-ylmethyl)phenyl]-2-furamide | 5-({2-nitro-4-methylphenoxy}methyl)-N-[4-(1H-pyrazol-1-ylmethyl)phenyl]-2-furamide | C23H20N4O5
| | |
| 4 | 331445-31-9 | 2-[({2-[4-(dimethylamino)phenyl]-1,3-benzoxazol-5-yl}imino)methyl]-4-nitro-6-methoxyphenol | 2-[({2-[4-(dimethylamino)phenyl]-1,3-benzoxazol-5-yl}imino)methyl]-4-nitro-6-methoxyphenol | C23H20N4O5
| | |
| 5 | | N-[2-{4-nitrophenyl}-1-({2-[1-(5-methyl-2-furyl)ethylidene]hydrazino}carbonyl)vinyl]benzamide | N-[2-{4-nitrophenyl}-1-({2-[1-(5-methyl-2-furyl)ethylidene]hydrazino}carbonyl)vinyl]benzamide | C23H20N4O5
| | |
| 6 | | p-(5-Cyano-2-hydroxy-1,4-dimethyl-6-oxo-1,6-dihydropyridin-3-ylazo)benzoic acid 2-phenoxyethyl ester | p-(5-Cyano-2-hydroxy-1,4-dimethyl-6-oxo-1,6-dihydropyridin-3-ylazo)benzoic acid 2-phenoxyethyl ester | C23H20N4O5
| | |
| 7 | 88938-37-8 | 4-[(5-氰基-1,6-二氢-2-羟基-1,4-二甲基-6-氧代-3-吡啶基)偶氮]苯甲酸-2-苯氧基乙基酯 | Benzoic acid, 4-(5-cyano-1,6-dihydro-2-hydroxy-1,4-dimethyl-6-oxo-3-pyridinyl)azo-, 2-phenoxyethyl ester | C23H20N4O5
| | |
| 8 | 448906-64-7 | 6-amino-3-(1,3-benzodioxol-5-yl)-4-(3-ethoxy-4-methoxyphenyl)-1,4-dihydropyrano[2,3-c]pyrazole-5-carbonitrile | 6-amino-3-(1,3-benzodioxol-5-yl)-4-(3-ethoxy-4-methoxyphenyl)-1,4-dihydropyrano[2,3-c]pyrazole-5-carbonitrile | C23H20N4O5
| | |
| 9 | 352684-07-2 | 6-hydroxy-5-{[1-(4-methoxyphenyl)-3-methyl-5-oxo-1,5-dihydro-4H-pyrazol-4-ylidene]methyl}-3-(4-methylphenyl)-2,4(1H,3H)-pyrimidinedione | 6-hydroxy-5-{[1-(4-methoxyphenyl)-3-methyl-5-oxo-1,5-dihydro-4H-pyrazol-4-ylidene]methyl}-3-(4-methylphenyl)-2,4(1H,3H)-pyrimidinedione | C23H20N4O5
| | |